Key result
UMIPIC follow-up linked to ~44% lower 12-month HF readmission and mortality versus primary care.
Why the study?
It was unclear whether alternative follow-up models in Internal Medicine departments provide additional benefits over exclusive Primary Care follow-up, and whether hospital-based consultations sustain their impact after clinical stability is achieved in multimorbid heart failure patients.
Does follow-up within the UMIPIC model reduce HF readmissions and all-cause mortality in patients with multimorbidity discharged after heart failure compared to Primary Care or non-UMIPIC Internal Medicine follow-up?
Cohort (n=709)
Does follow-up within the UMIPIC model reduce HF readmissions and all-cause mortality in patients with multimorbidity discharged after heart failure compared to Primary Care or non-UMIPIC Internal Medicine follow-up?
Hospital-based follow-up under the UMIPIC model during the first six months after an HF episode significantly reduces HF readmissions and overall mortality compared with exclusive Primary Care or conventional Internal Medicine follow-up in patients with multimorbidity.
Answers are grounded in this paper and cite their sources.
Supports integrated follow-up in multimorbid HF; leaves open whether benefits are causal without randomized confirmation.
BACKGROUND Follow-up within Integrated Management Units for Heart Failure (UMIPIC) in patients with multiple comorbidities discharged after heart failure (HF) improves outcomes during the acute phase. However, many Internal Medicine departments use alternative models, and it remains unclear whether these alternative approaches provide additional benefits compared to exclusive follow-up in Primary Care (PC), as well as whether hospital-based consultations maintain their impact once patient stability is achieved. METHODS We analyzed 709 H F discharges from the PROFUND-IC registry. After population weighting using inverse probability weighting (IPW), we assessed HF readmissions and all-cause mortality at 12 months, comparing patients followed in UMIPIC units, Internal Medicine outpatient clinics (non-UMIPIC), and exclusively in PC. Events occurring within the first 6 months after the acute phase were analyzed separately from those in the subsequent 6 months. RESULTS Patients managed under the UMIPIC models experienced a lower 12-month risk of events compared with PC (HR 0.56; 95% CI 0.38-0.84; p < 0.01) and non-UMIPIC (HR 0.58; 95% CI 0.36-0.93; p = 0.02); the latter showed no benefit over PC. Event reduction in UMIPIC was significant during the first 6 months (HR 0.56; 95% CI 0.38-0.83; p < 0.01), with no differences between models during the stable phase. CONCLUSIONS Hospital-based follow-up of patients with multiple comorbidities during the first six months after an HF episode reduces HF readmissions and overall mortality compared with exclusive PC follow-up-provided it is conducted under the UMIPIC model rather than through conventional Internal Medicine consultations.
No takes yet. Share an insight, caveat, or question.
Rodríguez et al. (2026) conducted a cohort in Heart failure with multiple comorbidities (n=709). UMIPIC model (Integrated Management Units for Heart Failure) vs. Internal Medicine outpatient clinics (non-UMIPIC) and exclusive Primary Care (PC) was evaluated on HF readmissions and all-cause mortality at 12 months (HR 0.56, 95% CI 0.38-0.84, p=<0.01). Follow-up under the UMIPIC model reduced the 12-month risk of HF readmissions and all-cause mortality compared with Primary Care and non-UMIPIC clinics.
Synapse has enriched 10 related papers. Consider them for comparative context: